{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:46:14Z","timestamp":1791499574489,"version":"4.3.4"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Transfus Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0973-6247.162684","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T04:58:47Z","timestamp":1439355527000},"page":"117","source":"Crossref","is-referenced-by-count":33,"title":["Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility"],"prefix":"10.4103","volume":"9","author":[{"given":"Serena","family":"Valsami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Dimitroulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyri","family":"Gialeraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chimonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Politou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-6247.162684-1","first-page":"197","volume-title":"Platelet transfusions: An historical perspective","author":"Blajchman","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.4103\/0973-6247.162684-2","first-page":"172","volume-title":"Evidence-based platelet transfusion guidelines","author":"Slichter","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.4103\/0973-6247.162684-3","first-page":"127","volume-title":"Consensus and controversies in platelet transfusion","author":"Marwaha","year":"2009","journal-title":"Transfus Apher Sci"},{"key":"key-10.4103\/0973-6247.162684-4","first-page":"221","volume-title":"Transfusions of fresh platelet concentrates to patients with secondary thrombocytopenia","author":"Djerassi","year":"1963","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-6247.162684-5","first-page":"615","volume-title":"The origin of ABH antigens on human platelets","author":"Dunstan","year":"1985","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-6","first-page":"196","volume-title":"Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib","author":"Santoso","year":"1991","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0973-6247.162684-7","first-page":"1387","volume-title":"Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets","author":"Tsuji","year":"1986","journal-title":"J Biochem"},{"key":"key-10.4103\/0973-6247.162684-8","first-page":"149","volume-title":"Biochemical characterisation of A blood group activity on human platelets","author":"Dunstan","year":"1985","journal-title":"Vox Sang"},{"key":"key-10.4103\/0973-6247.162684-9","first-page":"456","volume-title":"Minimal expression of blood group A antigen on thrombocytes from A2 individuals","author":"Skogen","year":"1988","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-10","first-page":"1574","volume-title":"Blood group A and B antigens are strongly expressed on platelets of some individuals","author":"Curtis","year":"2000","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-11","first-page":"993","volume-title":"Study on the expression of ABH antigens on platelets","author":"Ogasawara","year":"1993","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-12","first-page":"3356","volume-title":"Determinants of ABH expression on human blood platelets","author":"Cooling","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-13","first-page":"1378","volume-title":"PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage","author":"Julmy","year":"2003","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-14","first-page":"2260","volume-title":"Translation of glycoprotein IIIa in stored blood platelets","author":"Thon","year":"2007","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-15","first-page":"83","volume-title":"ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"key-10.4103\/0973-6247.162684-16","first-page":"2442","volume-title":"ABO-identical versus nonidentical platelet transfusion: A systematic review","author":"Shehata","year":"2009","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-17","first-page":"790","volume-title":"Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery","author":"Blumberg","year":"2001","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-18","first-page":"747","volume-title":"What would Karl Landsteiner do.The ABO blood group and stem cell transplantation?","author":"Heal","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"key-10.4103\/0973-6247.162684-19","first-page":"55","volume-title":"An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients","author":"Refaai","year":"2011","journal-title":"Vox Sang"},{"key":"key-10.4103\/0973-6247.162684-20","first-page":"1743","volume-title":"Practices associated with ABO-incompatible platelet transfusions: A BEST Collaborative international survey","author":"Lozano","year":"2010","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-21","first-page":"635","volume-title":"Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: Approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence","author":"Henrichs","year":"2012","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-22","first-page":"5553","volume-title":"The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia","author":"Triulzi","year":"2012","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-23","first-page":"1552","volume-title":"Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: An observational study","author":"Pavenski","year":"2010","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-24","first-page":"732","volume-title":"Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets","author":"Aster","year":"1965","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-25","first-page":"382","volume-title":"Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B","author":"Refaai","year":"2013","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-26","first-page":"207","volume-title":"Reporting results of cancer treatment","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"key-10.4103\/0973-6247.162684-27","first-page":"408","volume-title":"Transfusion of ABO-mismatched platelets leads to early platelet refractoriness","author":"Carr","year":"1990","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-6247.162684-28","first-page":"23","volume-title":"An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients","author":"Heal","year":"1987","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-29","first-page":"110","volume-title":"The role of ABO matching in platelet transfusion","author":"Heal","year":"1993","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/0973-6247.162684-30","first-page":"384","volume-title":"ABO compatibility can influence the results of platelet transfusion.Results of a randomized trial","author":"Lee","year":"1989","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-31","first-page":"51","volume-title":"Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets","author":"Mair","year":"1998","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-32","first-page":"57","volume-title":"The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility","author":"Lozano","year":"2003","journal-title":"Transfus Med Rev"},{"key":"key-10.4103\/0973-6247.162684-33","first-page":"974","volume-title":"Acute haemolysis after ABO-incompatible platelet transfusions","author":"Murphy","year":"1990","journal-title":"Lancet"},{"key":"key-10.4103\/0973-6247.162684-34","first-page":"2072","volume-title":"Hemolysis from platelet transfusion: Call to action for an underreported reaction","author":"Quillen","year":"2012","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-35","first-page":"2087","volume-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","author":"Karafin","year":"2012","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-36","first-page":"92","volume-title":"A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies","author":"Quillen","year":"2011","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-37","doi-asserted-by":"crossref","unstructured":"Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:207-21.","DOI":"10.1111\/j.1423-0410.2005.00615.x"},{"key":"key-10.4103\/0973-6247.162684-38","first-page":"2081","volume-title":"How we treat: Risk mitigation for ABO-incompatible plasma in plateletpheresis products","author":"Fontaine","year":"2012","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-39","first-page":"93","volume-title":"Current status of additive solutions for platelets","author":"Alhumaidan","year":"2012","journal-title":"J Clin Apher"},{"key":"key-10.4103\/0973-6247.162684-40","first-page":"273","volume-title":"High concentration plasma-reduced plateletapheresis concentrates","author":"Perseghin","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"key-10.4103\/0973-6247.162684-41","first-page":"125","volume-title":"Preparation of single donor platelet with low antibody titers for all patients","author":"Romphruk","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"key-10.4103\/0973-6247.162684-42","first-page":"2197","volume-title":"Detection of anti-D in D- recipients transfused with D+ red blood cells","author":"Yazer","year":"2007","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-43","first-page":"942","volume-title":"Rh-incompatible platelet transfusions - Risks and consequences of sensitizing immunosuppressed patients","author":"Goldfinger","year":"1971","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-6247.162684-44","first-page":"330","volume-title":"Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients","author":"Baldwin","year":"1988","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-45","first-page":"185","volume-title":"Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients","author":"McLeod","year":"1990","journal-title":"Vox Sang"},{"key":"key-10.4103\/0973-6247.162684-46","first-page":"177","volume-title":"Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets","author":"Molnar","year":"2002","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-47","first-page":"1163","volume-title":"Platelet transfusions from D+ donors to D\u2212 patients: A 10-year follow-up study of 1014 patients","author":"Cid","year":"2011","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-48","first-page":"453","volume-title":"Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients","author":"Cid","year":"2005","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-49","first-page":"1132","volume-title":"Residual risk of D alloimmunization: Is it time to feel safe about platelets from D+ donors?","author":"Shaz","year":"2011","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-50","first-page":"173","volume-title":"Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions","author":"Cid","year":"2002","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-51","first-page":"2546","volume-title":"Stochastic modeling of human RBC alloimmunization: Evidence for a distinct population of immunologic responders","author":"Higgins","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-52","first-page":"945","volume-title":"WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization","author":"Blumberg","year":"2003","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-53","first-page":"1070","volume-title":"Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?","author":"Yazer","year":"2009","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-54","first-page":"25","volume-title":"Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs","author":"King","year":"2004","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-55","doi-asserted-by":"crossref","unstructured":"Mollison PL, Engelfriet CP, Contreras M. The Rh blood group system (and LW). In: Klein HG, Anstee DJ, editors. Mollison\u2032s Blood Transfusion in Clinical Medicine. 11 th ed. Oxford, UK: Blackwell Publishing Ltd.; 2005. p. 163-208.","DOI":"10.1002\/9780470986868.ch5"},{"key":"key-10.4103\/0973-6247.162684-56","first-page":"1990","volume-title":"Prevention of D sensitization after mismatched transfusion of blood components: Toward optimal use of RhIG","author":"Ayache","year":"2008","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-57","first-page":"179","volume-title":"Human MHC architecture and evolution: Implications for disease association studies","author":"Traherne","year":"2008","journal-title":"Int J Immunogenet"},{"key":"key-10.4103\/0973-6247.162684-58","first-page":"227","volume-title":"Human platelet alloantigens","author":"Santoso","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"key-10.4103\/0973-6247.162684-59","first-page":"167","volume-title":"Ability of thrombocytes to acquire HLA specificity from plasma","author":"Lalezari","year":"1982","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-60","first-page":"1770","volume-title":"Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions","author":"Ghio","year":"1999","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-61","first-page":"702","volume-title":"The HLA system.First of two parts","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-6247.162684-62","first-page":"157","volume-title":"Immunoregulatory role of soluble HLA molecules: A new skin for an old subject?","author":"Puppo","year":"1998","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key-10.4103\/0973-6247.162684-63","first-page":"545","volume-title":"Allorecognition and the alloresponse: Clinical implications","author":"Afzali","year":"2007","journal-title":"Tissue Antigens"},{"key":"key-10.4103\/0973-6247.162684-64","first-page":"348","volume-title":"Platelet transfusion refractoriness","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-6247.162684-65","first-page":"724","volume-title":"Alloimmune platelet refractoriness: Incidence declines, unsolved problems persist","author":"Brand","year":"2001","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-66","first-page":"762","volume-title":"Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support","author":"Sanz","year":"2001","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-67","first-page":"655","volume-title":"New paradigms in the management of alloimmune refractoriness to platelet transfusions","author":"Vassallo","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"key-10.4103\/0973-6247.162684-68","first-page":"1208","volume-title":"Platelet transfusion the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing","author":"Yankee","year":"1969","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-6247.162684-69","first-page":"219","volume-title":"Successful transfusion of platelets \"mismatched\" for HLA antigens to alloimmunized thrombocytopenic patients","author":"Duquesnoy","year":"1977","journal-title":"Am J Hematol"},{"key":"key-10.4103\/0973-6247.162684-70","first-page":"1446","volume-title":"Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity","author":"Petz","year":"2000","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-71","first-page":"1680","volume-title":"HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients","author":"Nambiar","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0973-6247.162684-72","first-page":"2318","volume-title":"Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases","author":"Pai","year":"2010","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-73","first-page":"237","volume-title":"HLA alloimmunization against platelet transfusions: Pathophysiology, significance, prevention and management","author":"Pavenski","year":"2012","journal-title":"Tissue Antigens"},{"key":"key-10.4103\/0973-6247.162684-74","first-page":"633","volume-title":"Selection of platelets for refractory patients by HLA matching and prospective crossmatching","author":"Moroff","year":"1992","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-75","first-page":"3080","volume-title":"Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion","author":"Rioux-Mass\u00e9","year":"2014","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-76","first-page":"201","volume-title":"A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients","author":"Freedman","year":"1989","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-77","first-page":"180","volume-title":"Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets","author":"Elhence","year":"2014","journal-title":"Blood Transfus"},{"key":"key-10.4103\/0973-6247.162684-78","first-page":"2230","volume-title":"Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: A systematic review","author":"Pavenski","year":"2013","journal-title":"Transfusion"},{"key":"key-10.4103\/0973-6247.162684-79","first-page":"84","volume-title":"Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension","author":"Claas","year":"1981","journal-title":"Exp Hematol"},{"key":"key-10.4103\/0973-6247.162684-80","first-page":"3","volume-title":"Leukoreduced blood components: Advantages and strategies for its implementation in developing countries","author":"Sharma","year":"2010","journal-title":"Asian J Transfus Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0973-6247","issn-type":"print"},{"key":"key-10.4103\/0973-6247.162684-81","first-page":"106","volume-title":"Why implement universal leukoreduction?","author":"Bassuni","year":"2008","journal-title":"Hematol Oncol Stem Cell Ther"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:52Z","timestamp":1786649992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-6247.162684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["162684"],"URL":"https:\/\/doi.org\/10.4103\/0973-6247.162684","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}